I think this line in @VonDerLeyen's speech deserves elaborating on.

The problems with European vaccine roll-out *so far* have mostly been to do with national logistics problems and production bottlenecks, not with EU procurement.

EU countries aren't using all doses they have. https://twitter.com/DaveKeating/status/1359439081160273921

One reason for this is that EU countries are saving doses to give people their 2nd jab 3-4 weeks after the 1st.

The UK isn't, they're giving all doses immediately upon receipt and waiting for 12 weeks to give 2nd jab.

In next weeks, a supply problem related to procurement *is* expected to bite, because pharma companies aren't delivering what they promised.

So it might make sense for EU countries to revise their strategy and start giving out all doses they have. But that's a national decision.

The risk is that if EU countries start administering those saved 2nd doses as 1st jabs, the supply problems may still not be resolved in 4 weeks and people will get their 2nd jabs late.

US is still saving 2nd jabs, but they have no supply problem because they're not exporting.

In terms of Commission's responsibility:

-So far, EU joint procurement is not the reason for problems. But that's changing.

-It is now EC's responsibility to put pressure on pharma companies to deliver what they promised in procurement. The export mechanism is such an effort.

On separate issue of authorisation speed, it should be noted not a single EU country has suggested EU switch to faster-but-more-risky emergency use approval method (not even )

All governments defending joint procurement, EMA approval & export mechanism. https://twitter.com/DaveKeating/status/1359430509558906884?s=20